SC Johnson Chairman and CEO Fisk Johnson welcomed Her Excellency Samia Suluhu Hassan, President of the United Republic of Tanzania, to Racine to discuss their shared commitment to eradicating malaria.

In a recent article for Boston Business Journal, Dr. Kanchan Relwani highlights the importance of patient-focused drug development and how we seek to incorporate the patient voice into all we do.

The Royal Albert Hall announced that it has earned the WELL Health-Safety Rating for Facility Operations and Management through the International WELL Building Institute (IWBI).

Rosario credits her work family at Merck for supporting her through much of her recovery. With the recent loss of her parents, her co-workers came to her aid with powerful emotional support that helped her through the toughest times.

A successful entrepreneurial endeavor is one in which a founder can solve a serious problem that affects livelihoods or businesses.

CRB’s Christa Myers provides her insights from topics in our latest Horizons Life Sciences report including operation warp speed, project delivery strategy, and the digital future.

In 2019, Mianna Burnett, manager, Business Operations, Bristol Myers Squibb, and her husband were rocketed into the most trying time in their lives — her husband was diagnosed with cancer.

The Elementary and Secondary School Emergency Relief (ESSER) Fund creates a valuable opportunity to help students and staff return to in-person learning.

For 29-year-old Katharina Bauer, pole vaulting is her life’s passion. In April 2018, she was implanted with the Boston Scientific EMBLEMTM MRI S-ICD System.

This was the desperate radio telegram in January 1925 from Dr. Curtis Welch in Nome, Alaska, to all the major Alaska towns, to territorial Governor Scott Bone in Juneau

Anu Osinusi recently spoke with us about how hepatitis research and treatment have changed over her career, why HDV is considered the “forgotten virus” and what’s next for Gilead.

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of its new state-of-the-art Solution Center in São Paulo, Brazil.

This spring, GBM is expanding its reach as they team up with the Quest Diagnostics Foundation, as part of the Quest for Health Equity (Q4HE) initiative.

Building on nearly 30 years of history in hunting both new and evolving viruses like HIV and hepatitis, Abbott Virus Hunters sprang into action against COVID-19 knowing that the world needed diagnostic solutions.

Ceres applauds the National Association of Insurance Commissioners (NAIC) for its vote today to approve the revised Climate Risk Disclosure Survey.

To power the exponential growth of telehealth and telemedicine, Qualcomm Connected Healthcare collaborates with industry-leading healthcare companies to innovate and develop scalable end-to-end technologies for a variety of healthcare services

What happens when the medical caretakers are ill-equipped to care for your personal caretakers?
The answer — so far — for the cardiovascular care of women and people of color has not been encouraging.

A team from Boston Scientific Mass., set out to see if technology could predict a patient’s impending heart failure—and send an alert to their physician weeks before an episode occurs.

Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) announced the launch of a new campaign to promote balanced diets by offering customers more fruit and vegetable options.

Frank Chan, president of patient monitoring, explains how the pressures of the pandemic accelerated Medtronic’s development of patient monitoring systems that allowed for remote connection between caregiver and patient.

FedEx is a long-time supporter of Heart to Heart International, and through a recent donation helped the organization create cold chain storage capabilities.

As the founder and director of BCN Checkpoint, a community HIV program geared toward gay men and transgender women in Barcelona, Ferran Pujol has helped provide hope to those living with HIV for nearly 30 years.

Col. Craig Maceri, director, vaccines value chain management, never would have guessed that his career at Merck would someday benefit his role as a commander in the National Guard. But the COVID-19 pandemic took everyone by surprise.

Commercializing cell and gene therapies efficiently requires timely decisions about whether to engage a CDMO or develop internal manufacturing capacity. Sometimes the best solution is to do both.

For years, clinicians have used genomics to better inform treatment and personalize therapies. Now, Verici Dx, an immunodiagnostics company based in Tennessee (US), wants to turn that personalized medicine lens to a different field: kidney…